Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > TX Providers

Dr. Anton M. Melnyk Jr., MD, FACP

(2 Ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of Alberta Faculty of Medicine and Dentistry (1988)

1904 Pine Street Suite 1a
Abilene, TX 79601

(325) 672-4368

Dr. Anton M. Melnyk Jr., MD, FACP is a medical oncologist in Abilene, TX specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Alberta Faculty of Medicine and Dentistry in 1988 and has 37 years of experience. Dr. Anton M. Melnyk Jr., MD, FACP is affiliated with Hendrick Health, Texas Oncology and Hendrick Medical Center.

Office Locations

Address:

1100 N 19th Street Suite 1a
Abilene, TX 79601

Address:

1904 Pine Street Suite 1a
Abilene, TX 79601

Address:

1957 Antilley Road
Abilene, TX 79606

In The News

“"Valentine's Day is the perfect time to show your love and provide a gentle and necessary reminder with a postcard for loved ones to make an appointment for a cancer screening," Dr. Anton Melnyk of...”—"Valentines offer reminder for prostate exams, mammograms", Plainview Herald, July 2016

"Abilene Physician Took Part in Clinical Trial of New Cancer Drug", Texas Oncology

abdominal imaging	71
biological response modifier (BRM) therapy	290
blood draw	1671
chemotherapy	290
CT scan	168
doctor visit	1765
hospital care	814
inpatient care	814
lab tests	4598
minimally invasive procedures	331
nursing home care	59
pelvic imaging	71
port flush	27
thoracic (chest) imaging	209
X-rays	112

**Gender**
Male	225
Female	346

**Ethnicity**
Non-Hispanic White	523
Black	0
Hispanic	30
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	217
From 75 to 84	244
85 and over	71
Less than 65	39

Hypertension	66
High Cholesterol	41
Stroke	4
Ischemic Heart Disease	42
Depression	20
Chronic Kidney Disease	25
Asthma	6
Osteoperosis	8
Atrial Fibrilation	11
Heart Failure	27
Chronic Obstructive Pulmonary Disease	24
Diabetes	29
Dementia	10
Cancer	56

abdominal imaging	84
biological response modifier (BRM) therapy	372
blood draw	1702
chemotherapy	372
CT scan	197
doctor visit	1594
hospital care	891
inpatient care	891
lab tests	4667
minimally invasive procedures	344
nursing home care	74
pelvic imaging	84
port flush	52
thoracic (chest) imaging	259
X-rays	146

**Gender**
Male	225
Female	360

**Ethnicity**
Non-Hispanic White	533
Black	0
Hispanic	28
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	226
From 75 to 84	241
85 and over	71
Less than 65	47

Hypertension	69
High Cholesterol	42
Stroke	3
Ischemic Heart Disease	42
Depression	24
Chronic Kidney Disease	29
Asthma	6
Osteoperosis	10
Atrial Fibrilation	11
Heart Failure	26
Chronic Obstructive Pulmonary Disease	25
Diabetes	30
Dementia	11
Cancer	56

abdominal imaging	82
biological response modifier (BRM) therapy	421
blood draw	1685
chemotherapy	421
CT scan	169
doctor visit	1676
hospital care	575
inpatient care	575
lab tests	4486
minimally invasive procedures	388
nursing home care	47
pelvic imaging	82
port flush	45
thoracic (chest) imaging	216
X-rays	129

**Gender**
Male	392
Female	738

**Ethnicity**
Non-Hispanic White	1030
Black	0
Hispanic	56
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	446
From 75 to 84	456
85 and over	138
Less than 65	90

Hypertension	65
High Cholesterol	45
Stroke	5
Ischemic Heart Disease	41
Depression	22
Chronic Kidney Disease	30
Asthma	15
Osteoperosis	10
Atrial Fibrilation	12
Heart Failure	26
Chronic Obstructive Pulmonary Disease	24
Diabetes	29
Dementia	12
Cancer	55

abdominal imaging	81
biological response modifier (BRM) therapy	530
blood draw	1993
chemotherapy	530
CT scan	153
doctor visit	1815
hormone therapy	38
hospital care	545
inpatient care	545
lab tests	5250
minimally invasive procedures	531
pelvic imaging	81
port flush	83
preventive care	10
thoracic (chest) imaging	151
X-rays	79

**Gender**
Male	256
Female	410

**Ethnicity**
Non-Hispanic White	600
Black	0
Hispanic	44
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	271
From 75 to 84	267
85 and over	73
Less than 65	55

Hypertension	73
High Cholesterol	52
Stroke	3
Ischemic Heart Disease	44
Depression	24
Chronic Kidney Disease	33
Asthma	26
Osteoperosis	11
Atrial Fibrilation	12
Heart Failure	29
Chronic Obstructive Pulmonary Disease	23
Diabetes	32
Dementia	12
Cancer	50

abdominal imaging	59
biological response modifier (BRM) therapy	480
blood draw	1955
chemotherapy	480
CT scan	125
doctor visit	1803
hormone therapy	34
hospital care	403
inpatient care	403
lab tests	5554
minimally invasive procedures	545
pelvic imaging	59
port flush	85
thoracic (chest) imaging	161
X-rays	95

**Gender**
Male	269
Female	434

**Ethnicity**
Non-Hispanic White	629
Black	0
Hispanic	49
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	294
From 75 to 84	283
85 and over	82
Less than 65	44

Hypertension	74
High Cholesterol	44
Stroke	5
Ischemic Heart Disease	45
Depression	21
Chronic Kidney Disease	40
Asthma	7
Osteoperosis	11
Atrial Fibrilation	12
Heart Failure	26
Chronic Obstructive Pulmonary Disease	21
Diabetes	32
Dementia	13
Cancer	51

abdominal imaging	102
biological response modifier (BRM) therapy	428
blood draw	1757
chemotherapy	428
CT scan	207
doctor visit	1643
hormone therapy	40
hospital care	282
inpatient care	282
lab tests	5445
minimally invasive procedures	519
pelvic imaging	102
port flush	90
thoracic (chest) imaging	104

**Gender**
Male	262
Female	415

**Ethnicity**
Non-Hispanic White	602
Black	0
Hispanic	47
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	284
From 75 to 84	262
85 and over	80
Less than 65	51

Hypertension	72
High Cholesterol	51
Stroke	4
Ischemic Heart Disease	43
Depression	22
Chronic Kidney Disease	37
Asthma	6
Osteoperosis	10
Atrial Fibrilation	11
Heart Failure	25
Chronic Obstructive Pulmonary Disease	23
Diabetes	31
Dementia	11
Cancer	53

abdominal imaging	51
biological response modifier (BRM) therapy	304
blood draw	1350
chemotherapy	304
CT scan	133
doctor visit	1431
hormone therapy	58
hospital care	277
inpatient care	277
lab tests	4258
minimally invasive procedures	430
pelvic imaging	51
port flush	87
thoracic (chest) imaging	81

**Gender**
Male	284
Female	402

**Ethnicity**
Non-Hispanic White	608
Black	0
Hispanic	46
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	287
From 75 to 84	264
85 and over	93
Less than 65	42

Hypertension	75
High Cholesterol	58
Stroke	6
Ischemic Heart Disease	44
Depression	26
Chronic Kidney Disease	44
Asthma	6
Osteoperosis	13
Atrial Fibrilation	10
Heart Failure	24
Chronic Obstructive Pulmonary Disease	25
Diabetes	34
Dementia	14
Cancer	53

abdominal imaging	58
biological response modifier (BRM) therapy	525
blood draw	1379
chemotherapy	525
CT scan	137
doctor visit	1427
hormone therapy	50
hospital care	263
inpatient care	263
lab tests	4192
minimally invasive procedures	591
pelvic imaging	58
port flush	70
thoracic (chest) imaging	78

**Gender**
Male	260
Female	393

**Ethnicity**
Non-Hispanic White	580
Black	0
Hispanic	44
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	275
From 75 to 84	239
85 and over	96
Less than 65	43

Hypertension	71
High Cholesterol	53
Stroke	5
Ischemic Heart Disease	43
Depression	23
Chronic Kidney Disease	41
Asthma	5
Osteoperosis	13
Atrial Fibrilation	13
Heart Failure	25
Chronic Obstructive Pulmonary Disease	21
Diabetes	32
Dementia	14
Cancer	51

abdominal imaging	251
biological response modifier (BRM) therapy	1264
blood draw	3338
chemotherapy	1264
CT scan	518
doctor visit	3481
hormone therapy	145
hospital care	690
inpatient care	690
lab tests	11679
minimally invasive procedures	1501
pelvic imaging	251
port flush	235
radiation therapy	42
thoracic (chest) imaging	266

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Anton M. Melnyk Jr., MD, FACP for Medicare patients.

The highest averages for the top procedures that Dr. Anton M. Melnyk Jr., MD, FACP treated as a medical oncologist in Abilene, TX were lab tests, blood draw, minimally invasive procedures and inpatient care.

abdominal imaging	94
biological response modifier (BRM) therapy	513
blood draw	1870
chemotherapy	513
CT scan	202
doctor visit	1850
hormone therapy	60
hospital care	526
inpatient care	526
lab tests	5583
minimally invasive procedures	575
nursing home care	60
pelvic imaging	94
preventive care	10
radiation therapy	3
thoracic (chest) imaging	170
X-rays	112

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Anton M. Melnyk Jr., MD, FACP.

**Gender**
Female	318
Male	197

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	464
Native American / Alaskan Native	0
Hispanic	31
Other	0

**Age**
85 and over	64
75 to 84	205
Less than 65	37
65 to 74	209

Average of Total of Conditions of Medicare patients treated by Dr. Anton M. Melnyk Jr., MD, FACP From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Anton M. Melnyk Jr., MD, FACP treated were hypertension, cancer, high cholesterol and ischemic heart disease.

Hypertension	51
High Cholesterol	35
Stroke	3
Ischemic Heart Disease	31
Depression	16
Chronic Kidney Disease	25
Asthma	7
Osteoporosis	7
Heart Failure	18
Chronic Obstructive Pulmonary Disease	16
Diabetes	22
Atrial Fibrillation	8
Cancer	38
Dementia	8

Education & Training

Dr. Anton M. Melnyk Jr., MD, FACP graduated from University of Alberta Faculty of Medicine and Dentistry in 1988. He completed residency at University of Alberta Affiliated Hospitals. He is certified by the Hematology Internal Medicine Medical Oncology and has a state license in Texas.

Medical School: University of Alberta Faculty of Medicine and Dentistry (1988)

Residency: University of Alberta Affiliated Hospitals (1993)

Board Certification: Hematology Internal Medicine Medical Oncology

Licensed In: Texas

Affiliations & Hospitals

Dr. Anton M. Melnyk Jr., MD, FACP is associated with these hospitals and organizations:

Hendrick Health

Texas Oncology

Hendrick Medical Center

Ratings & Reviews

Dr. Anton M. Melnyk Jr., MD, FACP has an average of 1.0 out of 5 stars based on 2 ratings. We collect ratings and reviews of Dr. Anton M. Melnyk Jr., MD, FACP from all over the web to help you find the right in Abilene, TX.

Overall Rating

(2 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Anton M. Melnyk Jr., MD, FACP. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Lilly USA, LLC	$7,488 $7,488
TESARO, Inc.	$3,592 ZEJULA $3,592
CTI BioPharma Corp.	$1,833 Vonjo $1,833
F. Hoffmann-La Roche AG	$1,818 Non-Covered Product $1,818
Pfizer Inc.	$1,672 INLYTA $1,157	SUTENT $188	XTANDI $104	IBRANCE $103	ELIQUIS $73	Other $48
Other	$9,543 BRUKINSA $1,350	Aranesp $1,035	IMBRUVICA $409	KEYTRUDA $325	OPDIVO $303	Other $6,120

**Types of Payments**
Consulting Fee	$15,838
Food and Beverage	$6,554
Honoraria	$1,725
Travel and Lodging	$1,174
Education	$624
Other	$31

Research Payments

Dr. Anton M. Melnyk Jr., MD, FACP has received 444 research payments totaling $913,414.

Biography

Dr. Anton Melnyk's areas of specialization are adult hematology, adult oncology, and medical oncology; he sees patients in Abilene, TX. He attended the University of Alberta Faculty of Medicine and Dentistry and then went on to complete his residency at a hospital affiliated with the University of Alberta. Dr. Melnyk is professionally affiliated with Hendrick Health and Texas Oncology.